Botox 200 unit vials
Ended Awarded Last action
- Contract number
- SPE2DR26FQVR9
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $31,688
Award facts
- Contract value 100% obligated
- $31,687.68 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency issued a $31,687.68 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of BOTOX 200 unit vials. The delivery order, issued on December 3, 2025, is scheduled for completion by December 24, 2025, and carries no set-aside designation, indicating the vendor competed in unrestricted federal procurement. DMS Pharmaceutical Group is performing this delivery order under its single-award Indefinite Delivery Contract with the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, awarded on November 13, 2025, with a $499.999 billion ceiling and completion date of December 31, 2036.
Under the broader $30.3 billion PPV-G GEN V acquisition strategy, DMS Pharmaceutical Group serves as a regional prime vendor contractor authorized to supply a comprehensive range of pharmaceutical products—including branded and generic prescription drugs, over-the-counter medications, biologics, and medical consumables—to support Department of Defense military healthcare facilities worldwide. The company's established performance across numerous delivery orders demonstrates its capability to fulfill the specialized pharmaceutical requirements of the federal military medical system, with this BOTOX delivery representing one of multiple orders the vendor has fulfilled for DLA's Medical Supply Chain division.
Quick answers
Who was awarded contract SPE2DR26FQVR9?
SPE2DR26FQVR9 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on December 3, 2025.
How much is contract SPE2DR26FQVR9 worth?
The government has obligated $31,688 on SPE2DR26FQVR9.
Is contract SPE2DR26FQVR9 an order under another contract?
Yes. SPE2DR26FQVR9 is a delivery order under SPE2DR25D9247, an indefinite delivery contract.
Was contract SPE2DR26FQVR9 competed?
The extent of competition for SPE2DR26FQVR9 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award